Ivermectin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 3 mg
Reference Brands: Stromectol(US)
Category:
Medical Aid
Ivermectin tablets work by binding to parasite nerve and muscle receptors, causing paralysis and death. They effectively treat parasitic infections like onchocerciasis and strongyloidiasis. Benefits include rapid parasite clearance, improved symptoms, and reduced transmission, making ivermectin a cornerstone in antiparasitic therapy.
Ivermectin tablets is available in Tablet
and strengths such as 3 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ivermectin tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ivermectin tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ivermectin tablets are approved in the US and EU for treating parasitic infections, with regulatory oversight from the FDA and EMA. Their dossiers include comprehensive safety, efficacy, and manufacturing data, ensuring high-quality standards. In the US, ivermectin is approved for specific indications, while in the EU, it adheres to strict EMA regulations. Regulatory approval involves rigorous clinical evaluation, documentation, and compliance checks. For detailed insights into ivermectin’s regulatory status, approved dossiers, and market authorization processes, visit Pharmatradz. Stay informed on the latest regulatory updates and licensing requirements for ivermectin tablets in global markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing